# New Found Gold Corp.: overview

NFGC · NYSE · CIK 1840616 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nfgc.md) · [Financials](/companies/nfgc/financials.md) · [Filings](/companies/nfgc/filings.md) · [Insiders](/companies/nfgc/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | [5.8](/filings/0001104659-26-034548.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | [2.0%](/filings/0001104659-26-034548.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | [(1102.0%)](/filings/0001104659-26-034548.md) |
| Net margin | % | not reported | not reported | not reported | not reported | [(819.2%)](/filings/0001104659-26-034548.md) |
| Diluted EPS | $ per share | [(0.33)](/filings/0001104659-23-039232.md) | [(0.54)](/filings/0001104659-24-037200.md) | [(0.45)](/filings/0001410578-25-000406.md) | [(0.26)](/filings/0001104659-26-034548.md) | [(0.20)](/filings/0001104659-26-034548.md) |
| Free cash flow | $m | [(50.0)](/filings/0001104659-23-039232.md) | [(79.7)](/filings/0001104659-24-037200.md) | [(101)](/filings/0001410578-25-000406.md) | [(56.3)](/filings/0001104659-26-034548.md) | [(56.9)](/filings/0001104659-26-034548.md) |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nfgc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Merk Investments LLC](/funds/1302842.md) | 2026-06-30 | $25.2m | 16,312,500 |  | Added +11,562,500 |
| [SPROTT INC.](/funds/1512920.md) | 2026-06-30 | $16.1m | 10,474,172 |  | Added +2,749,142 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $12.6m | 8,142,889 |  | Added +527,903 |
| [Groupe la Francaise](/funds/2056088.md) | 2026-06-30 | $3.9m | 2,500,000 |  | Added +168,100 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $3.8m | 2,447,500 |  | Reduced −1,891,839 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $3.5m | 2,296,568 |  | Reduced −140,438 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.8m | 1,847,247 |  | Reduced −811,360 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $2.7m | 1,758,915 |  | Reduced −326,700 |
| [HEARTLAND ADVISORS INC](/funds/937394.md) | 2026-06-30 | $1.3m | 854,200 |  | Reduced −46,500 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.3m | 831,532 |  | Reduced −1,227,718 |

## Recent filings

[All 311 filings](/companies/nfgc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 21:00 ET | [6-K](/filings/0001062993-26-005501.md) | Report of a foreign private issuer, period 2026-10-22 | 0001062993-26-005501 |
| 2026-10-15 | 10:59 ET | [6-K](/filings/0001062993-26-005357.md) | Report of a foreign private issuer, period 2026-10-15 | 0001062993-26-005357 |
| 2026-09-16 | 10:50 ET | [6-K](/filings/0001062993-26-004976.md) | Report of a foreign private issuer, period 2026-09-16 | 0001062993-26-004976 |
| 2026-08-25 | 11:06 ET | [6-K](/filings/0001062993-26-004585.md) | Report of a foreign private issuer, period 2026-08-25 | 0001062993-26-004585 |
| 2026-08-14 | 21:16 ET | [6-K](/filings/0001062993-26-004438.md) | Report of a foreign private issuer, period 2026-08-14 | 0001062993-26-004438 |
| 2026-08-12 | 21:06 ET | [6-K](/filings/0001062993-26-004226.md) | Report of a foreign private issuer, period 2026-08-12 | 0001062993-26-004226 |
| 2026-08-12 | 21:00 ET | [6-K](/filings/0001840616-26-000003.md) | Report of a foreign private issuer, period 2026-06-30 | 0001840616-26-000003 |
| 2026-07-21 | 21:02 ET | [6-K](/filings/0001062993-26-003742.md) | Report of a foreign private issuer, period 2026-07-21 | 0001062993-26-003742 |
| 2026-07-06 | 11:11 ET | [6-K](/filings/0001062993-26-003511.md) | Report of a foreign private issuer, period 2026-07-06 | 0001062993-26-003511 |
| 2026-06-29 | 11:02 ET | [6-K](/filings/0001062993-26-003395.md) | Report of a foreign private issuer, period 2026-06-29 | 0001062993-26-003395 |

## Latest annual report

[Form 40-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-034548.md), filed Mar 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1840616
- Tickers: NFGC
- Exchange: NYSE
- SIC code: 1040 Gold and Silver Ores
- State of incorporation: A1
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.
